ArticleOncotarget2016

Cyr61 and YB-1 are novel interacting partners of uPAR and elevate the malignancy of triple-negative breast cancer.

Michaela C Huber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.